Virios Therapeutics, Inc. (VIRI) has 23 open-market insider trades by 7 insiders since 2020. The most active filer is William Pridgen, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| William Pridgen | Dir | — | 10 | $226K | 2023-08-21 |
| Gregory Scott Duncan | CEO | — | 4 | $189K | 2023-08-17 |
| David R. Keefer | Dir | — | 1 | $29K | 2022-01-04 |
| Abel de la Rosa | Dir | — | 1 | $24K | 2022-01-07 |
| Angela Walsh | SVP OF FINANCE | — | 2 | $16K | 2022-05-23 |
| Richard James Whitley | Dir | — | 4 | $14K | 2022-12-08 |
| John C. Thomas | Dir | — | 1 | $6K | 2022-01-04 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| William Pridgen | Director | Buy | $20K | 2023-08-21 |
| Gregory Scott Duncan | CEO | Buy | $31K | 2023-08-17 |
| Richard James Whitley | Director | Sell | $468 | 2022-12-08 |
| Gregory Scott Duncan | CEO | Buy | $34K | 2022-05-23 |
| Angela Walsh | SVP OF FINANCE | Buy | $9K | 2022-05-23 |
| Richard James Whitley | Director | Buy | $2K | 2022-05-18 |
Companies that share insiders with VIRI, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| William Pridgen | Director | Buy | $1K | 2022-05-18 |
| William Pridgen | Director | Buy | $59K | 2022-05-17 |
| William Pridgen | Director | Buy | $3K | 2022-03-29 |
| William Pridgen | Director | Buy | $12K | 2022-03-23 |
| William Pridgen | Director | Buy | $25K | 2022-01-27 |
| Abel de la Rosa | Director | Buy | $24K | 2022-01-07 |
| Richard James Whitley | Director | Buy | $10K | 2022-01-06 |
| John C. Thomas | Director | Buy | $6K | 2022-01-04 |
| David R. Keefer | Director | Buy | $29K | 2022-01-04 |